WOUND DEBRIDEMENT PRODUCTS MARKET ANALYSIS

Wound Debridement Products Market, By Product Type (Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Surgical Wound Debridement Devices, Mechanical Debridement Pads, Traditional Wound Debridement Devices, and Larval Therapy), By Application (Chronic Ulcers, Surgical Wounds, Traumatic Wounds, and Burn Cases) by End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, and Others (Nursing Facilities, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3784
Pages :180
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Global Wound Debridement Products Market- Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems reagrding transportation of drugs from one place to another.

However, the COVID-19 pandemic had negative impact on the global debridement products market. For instance, according to data publsihed by the commonwealth fund on May 19, 2020, the number of patient visits to hospitals and ambulatory practices declined nearly 60% by the beginning of pandemic in April 2020. Even after pandemic, number of visits were roughly one third lower than what was before the pandemic.

Global Wound Debridement Products Market: Restraint

High Cost Associated With Wound Care Management

The high cost associated with wound care management with advanced wound dressing material, wound care devices, and bioactive products is expected to hinder the market growth over the forecast period. For instance, according to article published by International Wound Journal, in June 2020, the gross healthcare cost per patient ranges from US$ 15,789 –US$ 17,761. This adds the cost of surgical dressings that are required to change every day. Apart from this, the treatment formulation suggested by healthcare practitioner also adds up the cost. Depending on duration of treatment the cost increases.